Correction: annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer
Mol Biomed
.
2024 Apr 2;5(1):16.
doi: 10.1186/s43556-024-00180-4.
Authors
Alexis Woodward
#
1
,
Benjamin Southard
#
1
,
Sampurna Chakraborty
1
,
Aaron O Bailey
2
3
,
Gabriela N F Faria
4
,
Patrick McKernan
1
,
Wajeeha Razaq
5
,
Roger G Harrison
6
7
Affiliations
1
Stephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK, USA.
2
Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
3
AbCellera Biologics Inc, Vancouver, BC, Canada.
4
School of Sustainable Chemical, Biological, and Materials Engineering, University of Oklahoma, Norman, OK, USA.
5
Stephenson Cancer Center, Oklahoma City, OK, USA.
6
School of Sustainable Chemical, Biological, and Materials Engineering, University of Oklahoma, Norman, OK, USA. rharrison@ou.edu.
7
Stephenson Cancer Center, Oklahoma City, OK, USA. rharrison@ou.edu.
#
Contributed equally.
PMID:
38564119
PMCID:
PMC10987452
DOI:
10.1186/s43556-024-00180-4
No abstract available
Publication types
Published Erratum